Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
pf-08046037 Non-Small Cell Lung Carcinoma	Pfizer	P1	CC (43)
pf-08046037 Pancreatic Ductal Adenocarcinoma	Pfizer	P1	CC (43)
pf-08046037 Head And Neck Squamous Cell Carcinoma	Pfizer	P1	CC (43)
PF-08046044 Hodgkins Lymphoma	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
PF-08046044 Anaplastic Large Cell Lymphoma	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
PF-08046044 Peripheral T-Cell Lymphoma, Not Otherwise Specified	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
pf-08046045 Hodgkins Lymphoma	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
pf-08046045 Anaplastic Large Cell Lymphoma	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
pf-08046045 Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
pf-08046045 Peripheral T-Cell Lymphoma, Not Otherwise Specified	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
pf-08046052 Head And Neck Squamous Cell Carcinoma	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
pf-08046876 Head And Neck Squamous Cell Carcinoma	Pfizer	P1	CC (43)
pf-08052666 Endometrial Disorder	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
ph-762 Cutaneous Neuroendocrine Carcinoma	Phio Pharmaceuticals Inc.	P1	CC (43)
ph-762 Skin Squamous Cell Carcinoma	Phio Pharmaceuticals Inc.	P1	CC (43)
Phase 1A: Lb-Lr1109 Non-Small Cell Lung Carcinoma	LG Chem	P1	CC (43)
Phin-214 Subcutaneous Fibrotic Liver Disease	PharmaIN	P1	CC (43)
Photochemotherapy Using 3-Ethyl-3-Deacetyl-Bacteriopurpurin-18-N-Butylimide Methyl Ester Brain Glioblastoma	Photolitec LLC	P1	CC (43)
Photochemotherapy Using 3-Ethyl-3-Deacetyl-Bacteriopurpurin-18-N-Butylimide Methyl Ester Gliosarcoma	Photolitec LLC	P1	CC (43)
Phox430 Glioblastoma	Phost'In Therapeutics	P1	CC (43)
Phox430 Cancer	Phost'In Therapeutics	P1	CC (43)
Phox430 Metastatic Malignant Neoplasm	Phost'In Therapeutics	P1	CC (43)
Phst001 Central Nervous System Neoplasm	Pheast Therapeutics	P1	CC (43)
Pidnarulex Cancer	Senhwa Biosciences, Inc.	P1	CC (43)
Pidnarulex Breast Cancer	National Cancer Institute (NCI)	P1	CC (43)

Showing 3851 to 3875 of 9,920 assets

PreviousPage 155 of 397Next